Molecular Bases of Drug Resistance in Hepatocellular Carcinoma

The poor outcome of patients with non-surgically removable advanced hepatocellular carcinoma (HCC), the most frequent type of primary liver cancer, is mainly due to the high refractoriness of this aggressive tumor to classical chemotherapy. Novel pharmacological approaches based on the use of inhibi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2020-06, Vol.12 (6), p.1663
Hauptverfasser:	Marin, Jose J.G., Macias, Rocio I.R., Monte, Maria J., Romero, Marta R., Asensio, Maitane, Sanchez-Martin, Anabel, Cives-Losada, Candela, Temprano, Alvaro G., Espinosa-Escudero, Ricardo, Reviejo, Maria, Bohorquez, Laura H., Briz, Oscar
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Cancer therapies Chemoresistance Chemotherapy Drug resistance Drug therapy Drugs Hepatocellular carcinoma Kinases Liver cancer Medical prognosis Metabolism Metabolites Plasma Proteins Review Tyrosine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!